Clinical Trial Update: Intravenous Labetalol Versus Hydralazine in Preeclampsia [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 clinical trial comparing intravenous labetalol and hydralazine for severe preeclampsia is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Preeclampsia

Drugs mentioned

• Hydralazine (hydralazine)
• labetalol (labetalol hydrochloride)

Snippet

Sponsor: Tanta University | Conditions: Preeclampsia Severe | Phase 1, Phase 2 | Status: RECRUITING